Work

The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.2525

Authors: Mengni Guo, Jieying Liu, Zohaib Ahmed, James Yu, Ruoyu Miao, Jian Guan, Mohammad Ali Esmaeil Pour, Azadeh Khayyat, Angela Grove, Manoucher Manoucheri, Mark A. Socinski, Tarek Mekhail

Institutions: AdventHealth Orlando, Harvard University, Houston Methodist, AdventHealth, Florida Hospital Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281640923

Cites:

Cited by:

Related to: 10